Bridgeway Capital Management’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Bridgeway Capital Management’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-84,700	Closed	-$563K	–	1530
2015 Q4	$563K	Hold	84,700	–	–	0.01%	1013
2015 Q3	$424K	Hold	84,700	–	–	0.01%	1105
2015 Q2	$453K	Buy	84,700 +54,300	+179%	+$385K	0.01%	1117
2015 Q1	$319K	Hold	30,400	–	–	0.01%	1240
2014 Q4	$382K	Buy	30,400 +300	+1%	+$4.09K	0.01%	1162
2014 Q3	$436K	Buy	+30,100	New	+$437K	0.01%	1144

Bridgeway Capital Management's TRIV Position: Q1 2016 in Review

Bridgeway Capital Management sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 84,700 shares — an estimated $563K sold.

Bridgeway Capital Management first reported a position in TRIV in Q3 2014 and held it in 6 quarters. The position peaked at $563K in Q4 2015. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

Bridgeway Capital Management reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Bridgeway Capital Management sold 84,700 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $563K.
Bridgeway Capital Management first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2014 and held it in 6 quarters.
Bridgeway Capital Management's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $563K in Q4 2015.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Bridgeway Capital Management's 13F filing for Q1 2016, filed 16 May 2016.